A new implant coating that releases antibiotics to prevent infections after surgery
Micrococcal nuclease-triggered antibiotics release: a prophylactic implant coating against S. aureus infections
This study is testing a new coating for surgical implants that releases antibiotics only when harmful bacteria are present, aiming to prevent infections in patients undergoing orthopedic surgeries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10896028 on NIH RePORTER |
What this research studies
This research focuses on developing a specialized coating for surgical implants that releases antibiotics in response to specific bacterial activity, particularly targeting Staphylococcus aureus, a common cause of infections in orthopedic surgeries. The approach utilizes a hydrogel that can release vancomycin, an antibiotic, only when triggered by the presence of the bacteria, thereby minimizing the risk of drug resistance and reducing the amount of antibiotic needed. By applying this coating to implants, the goal is to prevent infections before they can establish themselves and cause complications, such as osteomyelitis. The research involves testing this innovative coating in animal models to evaluate its effectiveness in preventing infections during and after surgery.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing orthopedic surgeries, such as joint replacements, who are at risk for periprosthetic infections.
Not a fit: Patients who are not undergoing orthopedic surgeries or those with existing infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of infections following orthopedic surgeries, leading to better patient outcomes and fewer complications.
How similar studies have performed: Previous research has shown promise in using targeted antibiotic delivery systems, indicating potential for success with this novel approach.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Song, Jie — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Song, Jie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.